Nipro Corporation

TSE:8086 Voorraadrapport

Marktkapitalisatie: JP¥226.4b

Nipro Beheer

Beheer criteriumcontroles 2/4

De CEO Nipro is Yoshihiko Sano, benoemd in May2012, heeft een ambtstermijn van 12.5 jaar. bezit rechtstreeks 0.068% van de aandelen van het bedrijf, ter waarde ¥ 154.28M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 10.6 jaar en 15.4 jaar.

Belangrijke informatie

Yoshihiko Sano

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO12.5yrs
Eigendom CEO0.07%
Management gemiddelde ambtstermijn10.6yrs
Gemiddelde ambtstermijn bestuur15.4yrs

Recente managementupdates

Recent updates

Some May Be Optimistic About Nipro's (TSE:8086) Earnings

Nov 15
Some May Be Optimistic About Nipro's (TSE:8086) Earnings

Market Participants Recognise Nipro Corporation's (TSE:8086) Earnings

Oct 16
Market Participants Recognise Nipro Corporation's (TSE:8086) Earnings

These 4 Measures Indicate That Nipro (TSE:8086) Is Using Debt In A Risky Way

Sep 28
These 4 Measures Indicate That Nipro (TSE:8086) Is Using Debt In A Risky Way

Nipro's (TSE:8086) Dividend Will Be ¥12.00

Aug 30
Nipro's (TSE:8086) Dividend Will Be ¥12.00

Nipro (TSE:8086) Has Announced A Dividend Of ¥12.00

Jul 25
Nipro (TSE:8086) Has Announced A Dividend Of ¥12.00

Nipro (TSE:8086) Will Pay A Dividend Of ¥12.00

Jul 11
Nipro (TSE:8086) Will Pay A Dividend Of ¥12.00

Nipro (TSE:8086) Has A Somewhat Strained Balance Sheet

Jun 06
Nipro (TSE:8086) Has A Somewhat Strained Balance Sheet

Earnings Tell The Story For Nipro Corporation (TSE:8086)

Apr 02
Earnings Tell The Story For Nipro Corporation (TSE:8086)

Nipro (TSE:8086) Will Pay A Larger Dividend Than Last Year At ¥15.00

Feb 27
Nipro (TSE:8086) Will Pay A Larger Dividend Than Last Year At ¥15.00

CEO

Yoshihiko Sano (79 yo)

12.5yrs

Tenure

Mr. Yoshihiko Sano serves as President since May 2012 and Representative Director of Nipro Corporation. Mr. Sano served as Managing Director of Nipro Corporation since June 2006 until May 2012. He is Chair...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yoshihiko Sano
Chairman of Board & President12.5yrsgeen gegevens0.068%
¥ 154.3m
Akihiko Yamabe
Manager of Accounting Department - Corporate Planning Division10.3yrsgeen gegevensgeen gegevens
Hideto Nakamura
GM of General Affairs10.3yrsgeen gegevens0.015%
¥ 35.0m
Kiyotaka Yoshioka
Senior MD12.4yrsgeen gegevens0.0061%
¥ 13.9m
Toshiaki Masuda
MD, Head of Planning and Development and Director9.4yrsgeen gegevens0.0084%
¥ 19.1m
Tsuyoshi Yamazaki
Senior MD9.8yrsgeen gegevens0.011%
¥ 25.5m
Kimihito Minoura
MD, Head of Regenerative Medicine and Business Promotion9.4yrsgeen gegevens0.018%
¥ 40.9m
Kazuhiko Sano
MD, GM of Facilities Division & Production Technology Center and Director10.6yrsgeen gegevens0.011%
¥ 24.6m
Kenichi Nishida
MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director12.1yrsgeen gegevens0.0037%
¥ 8.5m
Kyoetsu Kobayashi
MD, GM of the Stable Production & Crisis Management Division and Director10.6yrsgeen gegevens0.013%
¥ 28.5m
Toyoshi Yoshida
Director of Quality Assurance Division & Director13.6yrsgeen gegevens0.0094%
¥ 21.4m
Yasushi Oyama
MD, Head of Vascular Business Division & Directorno datageen gegevens0.012%
¥ 27.7m

10.6yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 8086 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.6 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Yoshihiko Sano
Chairman of Board & President31.8yrsgeen gegevens0.068%
¥ 154.3m
Hideto Nakamura
GM of General Affairs15.4yrsgeen gegevens0.015%
¥ 35.0m
Kiyotaka Yoshioka
Senior MD18.4yrsgeen gegevens0.0061%
¥ 13.9m
Toshiaki Masuda
MD, Head of Planning and Development and Directorno datageen gegevens0.0084%
¥ 19.1m
Tsuyoshi Yamazaki
Senior MDno datageen gegevens0.011%
¥ 25.5m
Kimihito Minoura
MD, Head of Regenerative Medicine and Business Promotion15.4yrsgeen gegevens0.018%
¥ 40.9m
Kazuhiko Sano
MD, GM of Facilities Division & Production Technology Center and Director14.4yrsgeen gegevens0.011%
¥ 24.6m
Kenichi Nishida
MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Directorno datageen gegevens0.0037%
¥ 8.5m
Kyoetsu Kobayashi
MD, GM of the Stable Production & Crisis Management Division and Directorno datageen gegevens0.013%
¥ 28.5m
Toyoshi Yoshida
Director of Quality Assurance Division & Director14.4yrsgeen gegevens0.0094%
¥ 21.4m
Yasushi Oyama
MD, Head of Vascular Business Division & Directorno datageen gegevens0.012%
¥ 27.7m
Takehito Yogo
Senior MD18.2yrsgeen gegevens0.0043%
¥ 9.8m

15.4yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 8086 zijn ervaren en ervaren (gemiddelde ambtstermijn van 15.4 jaar).